Bioceres Crop Solutions Corp. (NASDAQ:BIOX – Get Free Report) saw a large decline in short interest during the month of November. As of November 30th, there was short interest totalling 667,800 shares, a decline of 10.7% from the November 15th total of 747,900 shares. Approximately 2.1% of the company’s stock are short sold. Based on an average daily volume of 184,500 shares, the short-interest ratio is currently 3.6 days.
Bioceres Crop Solutions Price Performance
Bioceres Crop Solutions stock traded up $0.05 during trading hours on Friday, hitting $6.66. 120,315 shares of the company traded hands, compared to its average volume of 100,017. Bioceres Crop Solutions has a 1-year low of $5.71 and a 1-year high of $14.05. The firm has a market cap of $418.58 million, a P/E ratio of 333.17 and a beta of 0.51. The firm’s 50-day simple moving average is $6.85 and its two-hundred day simple moving average is $9.01. The company has a quick ratio of 0.87, a current ratio of 1.27 and a debt-to-equity ratio of 0.37.
Bioceres Crop Solutions (NASDAQ:BIOX – Get Free Report) last issued its quarterly earnings results on Monday, November 11th. The company reported ($0.09) EPS for the quarter, missing the consensus estimate of $0.02 by ($0.11). The business had revenue of $92.60 million during the quarter, compared to the consensus estimate of $117.15 million. Bioceres Crop Solutions had a return on equity of 0.68% and a net margin of 0.53%. During the same quarter last year, the firm posted ($0.07) earnings per share. As a group, analysts forecast that Bioceres Crop Solutions will post 0.12 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Bioceres Crop Solutions
Analyst Upgrades and Downgrades
Several brokerages have issued reports on BIOX. Roth Mkm cut their price objective on Bioceres Crop Solutions from $15.00 to $13.00 and set a “buy” rating on the stock in a research note on Wednesday, September 11th. Oppenheimer lowered their price objective on shares of Bioceres Crop Solutions from $16.00 to $13.00 and set an “outperform” rating for the company in a research report on Monday, October 21st. Lake Street Capital dropped their price target on Bioceres Crop Solutions from $25.00 to $13.00 and set a “buy” rating on the stock in a research report on Wednesday, September 11th. Finally, Canaccord Genuity Group lowered their price objective on Bioceres Crop Solutions from $10.00 to $9.50 and set a “buy” rating for the company in a research note on Wednesday, November 13th. Four research analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, Bioceres Crop Solutions has an average rating of “Buy” and a consensus price target of $12.13.
Check Out Our Latest Analysis on Bioceres Crop Solutions
Bioceres Crop Solutions Company Profile
Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.
Read More
- Five stocks we like better than Bioceres Crop Solutions
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Dave & Buster’s: Is It Time to Make Another Play on This Stock?
- Using the MarketBeat Dividend Yield Calculator
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- What is a Bond Market Holiday? How to Invest and Trade
- Texas Instruments: The Old-School Tech Titan Still Delivering
Receive News & Ratings for Bioceres Crop Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioceres Crop Solutions and related companies with MarketBeat.com's FREE daily email newsletter.